e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Allergen immunotherapy and anti-immunoglobulin E
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cytokine production profile of T-lymphocytes and frequence of regulatory T-cells in patients with allergic asthma receiving anti-IgE therapy
I. Haasler, J. Weber, I. Bellinghausen, S. Korn, J. Saloga, R. Buhl, C. Taube (Mainz, Germany)
Source:
Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Session:
Allergen immunotherapy and anti-immunoglobulin E
Session type:
Poster Discussion
Number:
278
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Haasler, J. Weber, I. Bellinghausen, S. Korn, J. Saloga, R. Buhl, C. Taube (Mainz, Germany). Cytokine production profile of T-lymphocytes and frequence of regulatory T-cells in patients with allergic asthma receiving anti-IgE therapy. Eur Respir J 2011; 38: Suppl. 55, 278
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Study of the effect of IL-4 and IFN-γ on Th1/Th2 cells and mast cells in allergic asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 271s
Year: 2001
Follicular T helper and Breg cell balance in severe allergic asthma before and after omalizumab therapy
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021
Reduced numbers of circulating CD4
+
CD25
high
FOXP3
+
regulatory T cells in patients with allergic asthma
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008
Distinctive gene signature of allergen-specific CD4+T cells in allergic patients
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017
Expression of surface markers on peripheral CD4
+
CD25
high
T cells in patients with atopic asthma: role of inhaled corticosteroid
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Cytokine expression and frequency of allergen specific T-cells in adult asthma and atopy
Source: Eur Respir J 2001; 18: Suppl. 33, 530s
Year: 2001
Theophylline and budesonide downregulate production of cytokines by blood T lymphocytes of patients with COPD
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Effect of BCG-PSN on Th1 and Th2 cytokine responses of peripheral blood mononuclear cells from atopic asthmatics
Source: Eur Respir J 2003; 22: Suppl. 45, 547s
Year: 2003
Regulatory T cells and L-selectin in severe asthmatic patients treated with mepolizumab.
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status?
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Allergen-specific immunotherapy results in increased IL-10 production of mononuclear cells and T-cell anergy
Source: Eur Respir J 2003; 22: Suppl. 45, 110s
Year: 2003
Omalizumab decreases IgE production in patients with severe allergic asthma
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012
The influence of the allergen-specific immunotherapy (ASIT) against the backdrop of an immunomodulator in patients suffering from seasonal allergic rhinitis (SAR) on the level of cytokines, IgE and IgG.
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020
Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions
Source: Eur Respir J 2003; 21: 799-803
Year: 2003
Peripheral blood Th17 cells and serum IL-17 levels in patients with
D. pteronyssinus
-
induced late-phase asthmatic response
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease
Source: Eur Respir J 2007; 30: 383-390
Year: 2007
T-cell co-stimulatory molecules: their role in allergic immune reactions
Source: Eur Respir J 2007; 29: 1246-1255
Year: 2007
Analysis of cytokine signaling through the STAT6 activation in patients with atopic steroid-free asthma
Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Year: 2007
Chemokine-receptor expression on allergen-specific T cells in allergic asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2007; 30: Suppl. 51, 372s
Year: 2007
The impact of sublingual immunotherapy (SLIT) of asthma on Th1 cells susceptibility to apoptosis
Source: Annual Congress 2012 - Predicting and observing paediatric allergic disease
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept